5 alpha-androst-16-en-3-one,
5alpha-androst-16-en-3-one,
AEON steroid,
androst-16-en-3-one,
androst-16-en-3-one, (5beta)-isomer,
5alpha-Androst-16-en-3-one,
androstenone,
18339-16-7,
UNII-BWD3D5941J,
Androst-16-en-3-one,
MLS000069748,
BWD3D5941J,
CHEBI:37894,
HFVMLYAGWXSTQI-QYXZOKGRSA-N,
Androst-16-en-3-one, (5a)-,
Androst-16-en-3-one, (5alpha)-,
NCGC00167559-01,
SMR000059223,
(5S,8R,9S,10S,13R,14S)-10,13-Dimethyl-4,5,6,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3(2H)-one,
16-(5alpha)Androsten-3-one,
3-Keto-5alpha,16-androstene,
(5alpha)-androst-16-en-3-one,
5.alpha.-Androst-16-en-3-one,
EINECS 242-220-1,
Androst-16-en-3-one, (5.alpha.)-,
5.alpha.-Androstenone,
5alpha-Androst-16-en-3-one;Androstenone,
Opera_ID_590,
AC1OAA1G,
5-androst-16-en-3-one,
DSSTox_CID_20965,
DSSTox_RID_79607,
DSSTox_GSID_40965,
5?-Androst-16-en-3-one,
3-Keto-5|A,16-androstene,
SCHEMBL219128,
16-(5|A)Androsten-3-one,
5|A-Androst-16-en-3-one,
CHEMBL1309552,
DTXSID0040965,
CTK0H5288,
HMS2232H12,
ZINC4352602,
Tox21_112554,
LMST02020079,
MFCD00010479,
AKOS015913988,
EBD3059886,
DS-13656,
O048,
CAS-18339-16-7,
DB-049952,
339A167,
I14-45154,
(5S,8R,9S,10S,13R,14S)-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15-dodecahydrocyclopenta[a]phenanthren-3-one,
(5S,8R,9S,10S,13R,14S)-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15-dodecahydrocyclopenta[a]phenanthren-3-one, 97%,
5a-androst-16-en-3-one,
C19H28O,
C19-H28-O,
ZINC04352601,
CID6852393,
ANDROSTENONE; OCCLESTERONE; 5WEI -ANDROSTENONE; EINECS 242-220-1; ANDROST-16-EN-3-ONE; 16-(5WEI )ANDROSTEN-3-ONE; 5ANDROSTAN-16-EN-3-ONE; 5A-ANDROST-16-EN-3-ONE; 16,(5A)-ANDROSTEN-3-ONE; ALPHA-ANDROST-16-EN-3-ONE,